Medicine
Lucemyra 0.2 mg tablet
Lucemyra 0.2 mg tablet is a prescription medicine containing Lofexidine for oral use, marketed by BioCorRx Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in original container at controlled room temperature, 25°C (77°F), with…
Key facts
- Active ingredient (INN)
- Lofexidine
- Brand
- Lucemyra
- Strength
- 0.2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 36 tablets, 96 tablets, 1 bottle and 1 more
- Marketing authorisation holder
- BioCorRx Pharmaceuticals
- Manufacturers
- BioCorRx PharmaceuticalsUswm
- Origin register
- US FDA, United States
- Storage
- Store in original container at controlled room temperature, 25°C (77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07BC04 Lofexidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 February 2021
- Identifiers
- RxCUI 2046591, 2046597DailyMed set ID b748f308-ba71-4fd9-84ec-ec7e0f210885, 0a848cc2-4dda-40d9-8b01-d789fe8981edNDC 78670-050, 85789-801Application NDA209229
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 36 tablet, film coated in 1 bottle | 85789-801-36 | BioCorRx Pharmaceuticals | 15 August 2026 |
| 96 tablet, film coated in 1 bottle | 85789-801-96 | BioCorRx Pharmaceuticals | 15 August 2026 |
| 1 bottle in 1 carton / 36 tablet, film coated in 1 bottle | 78670-050-36 | Uswm | 9 February 2021 |
| 1 bottle in 1 carton / 96 tablet, film coated in 1 bottle | 78670-050-96 | Uswm | 9 February 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 May 2018 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lofexidine 0.2 mg tablet.
Other strengths and forms of Lofexidine
Clinical summary
Lofexidine is a prescription medicine indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. It is available as tablets for oral use. MedsAcross supplies Lofexidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LofexidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LOFEXIDINE prescribing information (BioCorRx Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Lucemyra 0.2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.